Recent studies on SCLC showed that the effect of the combination therapy with DDR inhibitors was correlated with the activity of DNA repair response in patients and that DDR inhibitors could trigger STING‐IFN activation in SCLC models.20, 22. The gene discussed is IFNA1; the disease is small cell lung carcinoma.